Advanced search
Publication Cover
Future Medicinal Chemistry Volume 12, 2020 - Issue 24
Submit an article Journal homepage
450
Views
1
CrossRef citations to date
0
Altmetric
Review

N-Heterocyclic Carbene-Metal Complexes as Bio-Organometallic Antimicrobial and Anticancer Drugs, an Update (2015–2020)

Siddappa A Patil1 Centre for Nano & Material Sciences, Jain University, Jain Global Campus, Kanakapura, Ramanagaram, Bangalore562112, IndiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-2855-5302
ORCID Icon,
Amy P Hoagland2 Department of Chemistry & Physics, Florida Gulf Coast University, Fort Myers, FL33965, USA
,
Shivaputra A Patil3 Pharmaceutical Sciences Department, College of Pharmacy, Rosalind Franklin University of Medicine & Science, 3333 Green Bay Road, North Chicago, IL60064, USAORCID Iconhttps://orcid.org/0000-0001-6959-524X
ORCID Icon &
Alejandro Bugarin2 Department of Chemistry & Physics, Florida Gulf Coast University, Fort Myers, FL33965, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8504-355X
ORCID Icon
Pages 2239-2275 | Received 28 May 2020, Accepted 28 Sep 2020, Published online: 24 Nov 2020

References

  • Ho GY , WoodwardN , CowardJI. Cisplatin versus carboplatin: comparative review of therapeutic management in solid malignancies. Crit. Rev. Oncol. Hematol.102, 37–46 (2016).
  • Lokich J , AndersonN. Carboplatin versus cisplatin in solid tumors: an analysis of the literature. Ann Oncol.9(1), 13–21 (1998).
  • Lebwohl D , CanettaR. Clinical development of platinum complexes in cancer therapy: an historical perspective and an update. Eur. J. Cancer.34(10), 1522–1534 (1998).
  • Dasari S , TchounwouPB. Cisplatin in cancer therapy: molecular mechanisms of action. Eur. J. Pharmacol.740, 364–378 (2014).
  • Walker EM Jr , WalkerSM. Evolution of chemotherapy with platinum compounds. Ann Clin. Lab. Sci.29(4), 263–274 (1999).
  • Drews J . Drug discovery: a historical perspective. Science287(5460), 1960–1964 (2000).
  • Ratti E , TristD. Continuing evolution of the drug discovery process in the pharmaceutical industry. Pure Appl. Chem.73, 67–75 (2001).
  • Subapriya R , NaginiS. Medicinal properties of neem leaves: a review. Curr. Med. Chem.: Anti-Cancer Agents5(2), 149–156 (2005).
  • Zhu JS , HalpernGM , JonesK. The scientific rediscovery of an ancient Chinese herbal medicine: Cordyceps sinensis: part I. J. Altern. Complement. Med.4(3), 289–303 (1998).
  • Venita J . Paul Ehrlich. Arch. Pathol. Lab. Med.125, 725–725 (2001).
  • Fleming A . On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. Influenzae. Brit. J. Exp. Pathol.10, 226–236 (1929).
  • Walsh C , WrightG. Introduction: antibiotic resistance. Chem. Rev.105, 391–394 (2005).
  • Gould IM . Coping with antibiotic resistance: the impending crisis. Int. J. Antimicrob. Agents36, S1–S2 (2010).
  • Piddock LJ . The crisis of no new antibiotics – what is the way forward?Lancet Infect. Dis.12, 249–253 (2012).
  • Padiyara P , InoueH , SprengerM. Global governance mechanisms to address antimicrobial resistance. Infect. Dis. Res. Treat.11, 1–4 (2018).
  • Chattopadhyay MK , ChakrabortyR , GrossartHPet al. Antibiotic resistance of bacteria. Biomed. Res. Int.2015, 501658 (2015).
  • Infectious Diseases Society of America . The 10 x 20 initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020. Clin. Infect. Dis.50(8), 1081–1083 (2010).
  • Sekhon BS . Metalloantibiotics and antibiotic mimics-an overview. J. Pharm. Educ. Res.1, 1–20 (2010).
  • Johnstone TC , SuntharalingamK , LippardSJ. The next generation of platinum drugs: targeted Pt(II) agents, nanoparticle delivery, and Pt (IV) prodrugs. Chem. Rev.116, 3436–3486 (2016).
  • Basu U , BanikB , WenRet al. The Platin-X series: activation, targeting, and delivery. Dalton Trans.45, 12992–13004 (2016).
  • Bray F , FerlayJ , SoerjomataramIet al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.68(6), 394–424 (2018).
  • Ferlay J , ColombetM , SoerjomataramIet al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int. J. Cancer.44(8), 1941–1953 (2019).
  • Bailon-Moscoso N , Romero-BenavidesJC , Ostrosky-WegmanP. Development of anticancer drugs based on the hallmarks of tumor cells. Tumor Biol.35, 3981–3995 (2014).
  • Brown C . Targeted therapy: an elusive cancer target. Nature537, S106–S108 (2016).
  • Widmer N , BardinC , ChatelutEet al. Review of therapeutic drug monitoring of anticancer drugs part two-targeted therapies. Eur. J. Cancer50, 2020–2036 (2014).
  • Longley DB , JohnstonPG. Molecular mechanisms of drug resistance. J. Pathol.205, 275–292 (2005).
  • Mansoori B , MohammadiA , DavudianSet al. The different mechanisms of cancer drug resistance: a brief review. Adv. Pharm. Bull.7(3), 339–348 (2017).
  • Zahreddine H , BordenKL. Mechanisms and insights into drug resistance in cancer. Front Pharmacol.4, 28 (2013).
  • Patil SA , PatilSA , PatilRet al. N-heterocyclic carbene metal complexes as bioorganometallic antimicrobial and anticancer drugs. Future Med. Chem.7(10), 1305–1333 (2015).
  • Wanzlick HW , KleinerHJ. Nucleophile carben-chemiedarstellung des bis-[1.3-diphenyl-imidazolidinyliden-(2)]. Angew. Chem.73(14), 493 (1961).
  • Wanzlick HW . Aspects of nucleophilic carbine chemistry. Angew. Chem. Int. Ed. Engl.1(2), 75–80 (1962).
  • Wanzlick HW , EsserF , KleinerHJ. Nucleophile carbenchemie, III. neueverbindungenvomtyp des bis-[1.3-diphenyl-imidazolidinylidens-(2)]. Chem. Ber.96(5), 1208–1212 (1963).
  • Öfele K . 1,3-Dimethyl-4-imidazolinyliden-(2)-pentacarbonyl chromeinneuerüberga- ngsmetall-carbenkomplex. J. Organomet. Chem.12(3), P42–P43 (1968).
  • Wanzlick HW , SchönherrHJ. Direct synthesis of a mercury salt-carbene complex. Angew. Chem. Int. Ed. Engl.7(2), 141–142 (1968).
  • Arduengo AJ , HarlowRL , KlineMJ. A stable crystalline carbine. J. Am. Chem. Soc.113(1), 361–363 (1991).
  • Michalak M , KośnikW. Chiral N-heterocyclic carbene gold complexes: synthesis and applications in catalysis. Catalysts9(11), 890 (2019).
  • Velazquez HD , VerpoortF. N-heterocyclic carbene transition metal complexes for catalysis in aqueous media. Chem. Soc. Rev.41(21), 7032–60 (2012).
  • Bourissou D , GuerretO , GabbaiFPet al. Stable carbenes. Chem. Rev.100(1), 39–92 (2000).
  • Oehninger L , RubbianiR , OttI. N-heterocyclic carbene metal complexes in medicinal chemistry. Dalton Trans.42, 3269–3284 (2013).
  • Smith CA , NarouzMR , LummisPAet al. CM, N-heterocyclic carbenes in materials chemistry. Chem. Rev.119(8), 4986–5056 (2019).
  • Diez-Gonzalez S , MarionN , NolanSP. N-heterocyclic carbenes in late transition metal catalysis. Chem. Rev.109(8), 3612–3676 (2009).
  • Poyatos M , McNamaraW , IncarvitoCet al. A weak donor, planar chelating bitriazole N-heterocyclic carbene ligand for ruthenium(II), palladium(II), and rhodium. Organometallics27(9), 2128–2136 (2008).
  • Poyatos M , McNamaraW , IncarvitoCet al. A planar chelating bitriazole N-heterocyclic carbeneligand and its rhodium(III) and dirhodium(II) complexes. Chem. Commun.22, 2267–2269 (2007).
  • Gnanamgari D , MooresA , RajaseelanEet al. Transfer hydrogenation of imines and alkenes and direct reductive amination of aldehydes catalyzed by triazole-derived iridium(I) carbene complexes. Organometallics26, 1226–1230 (2007).
  • Crabtree RH . Abnormal, mesoionic and remote N-heterocyclic carbene complexes. Coord. Chem. Rev.257(3–4), 755–766 (2013).
  • Wang W , WangF , ShiM. Bis(NHC)-palladium(II) complex-catalyzed dioxygenation of alkenes. Organometallics29(4), 928–933 (2010).
  • Alcarazo M , StorkT , AnoopAet al. Steering the surprisingly modular π-acceptor properties of N-heterocyclic carbenes: implications for gold catalysis. Angew. Chem. Int. Ed.49(14), 2542–2546 (2010).
  • Buscemi G , BasatoM , BiffisAet al. C. Electronic properties of chelating dicarbene palladium complexes: a combined electrochemical, NMR and XPS investigation. J. Organomet. Chem.695(21), 2359–2365 (2010).
  • Frémont P , MarionN , NolanSP. Carbenes: synthesis, properties, and organometallic chemistry. Coord. Chem. Rev.253(7–8), 862–892 (2009).
  • Wang Z , JiangL , MohamedDKBet al. N-heterocyclic carbene complexes of group 6 metals. Coord. Chem. Rev.93–294, 292–326 (2015).
  • Schuster O , YangLR , RaubenheimerHGet al. Beyond conventional N-heterocyclic carbenes: abnormal, remote, and other classes of NHC ligands with reduced heteroatom stabilization. Chem. Rev.109(8), 3445–3475 (2009).
  • Poyatos M , MataJA , PerisE. Complexes with poly(N-heterocyclic carbene) ligands: structural features and catalytic applications. Chem. Rev.109(8), 3677–3707 (2009).
  • Enders D , NiemeierO , HenselerA. Organocatalysis by N-heterocyclic carbenes. Chem. Rev.107(12), 5606–5655 (2007).
  • Hurst EC , WilsonK , FairlambIJS , ChechikV. N-heterocyclic carbene coated metal nanoparticles. New J. Chem.33, 1837–1840 (2009).
  • Lara P , Rivada-WheelaghanO , ConejeroSet al. Ruthenium nanoparticles stabilized by N-heterocyclic carbenes: ligand location and influence on reactivity. Angew. Chem. Int. Ed.50(50), 12080–12084 (2011).
  • Vignolle J , TilleyTD. N-Heterocyclic carbene-stabilized gold nanoparticles and their assembly into 3D superlattices. Chem. Commun.46, 7230–7232 (2009).
  • Hopkinson MN , RichterC , SchedlerM , GloriusF. An overview of N-heterocyclic carbenes. Nature510, 485–496 (2014).
  • Lee KM , LeeCK , LinIJB. A facile synthesis of unusual liquid-crystalline gold(I) dicarbene compounds. Angew. Chem., Int. Ed. Engl.36, 1850–1852 (1997).
  • Hsu SJ , HsuKM , LeongMKet al. Au(I)-benzimidazole/imidazole complexes. liquid crystals and nanomaterials. Dalton Trans.1924–1931 (2008).
  • Fujihara T , OboraY , TokunagaMet al. Dendrimer N-heterocyclic carbene complexes with rhodium(I) at the core. Chem. Commun.4526–4528 (2005).
  • Boydston AJ , RiceJD , SandersonMDet al. Synthesis and study of bidentate benzimidazolylidene-group 10 metal complexes and related main-chain organometallic polymers. Organometallics25(26), 6087–6098 (2006).
  • Herrmann WA , KöcherC. N-heterocyclic carbenes. Angew. Chem. Int. Ed.36(20), 2162–2187 (1997).
  • Herrmann WA . N-heterocyclic carbenes: a new concept in organometallic catalysis. Angew. Chem. Int. Ed.41(8), 1290–1309 (2002).
  • Herrmann WA , ElisonM , FischerJet al. Metal complexes of N-heterocyclic carbenes-a new structural principle for catalysts in homogeneous catalysis. Angew. Chem. Int. Ed. Engl.34(21), 2371–2374 (1995).
  • Weskamp T , SchattenmannWC , SpieglerM , HerrmannWA. A novel class of ruthenium catalysts for olefin metathesis. Angew. Chem. Int. Ed.37(18), 2490–2493 (1998).
  • Melaiye A , SimonsRS , MilstedAet al. Formation of water-soluble pincer silver(I)-carbene complexes: a novel antimicrobial agent. J. Med. Chem.47(4), 973–977 (2004).
  • Melaiye A , SunZ , HindiKet al. Silver(I)-imidazole cyclophane gem-diol complexes encapsulated by electrospun tecophilic nanofibers: formation of nanosilver particles and antimicrobial activity. J. Am. Chem. Soc.127(7), 2285–2291 (2005).
  • Barnard PJ , BakerMV , Berners-PriceSJet al. Mitochondrial permeability transition induced by dinuclear gold(I)-carbene complexes: potential new antimitochondrial antitumour agents. J. Inorg. Biochem.98(10), 1642–1647 (2004).
  • Barnard PJ , BakerMV , Berners-PriceSJet al. Dinuclear gold(I) complexes of bridging bidentate carbene ligands: synthesis, structure and spectroscopic characterization. Dalton Trans.1038–1047 (2004).
  • Baker MV , BarnardPJ , Berners-PriceSJet al. Synthesis and structural characterisation of linear Au(I) N-heterocyclic carbene complexes: new analogues of the Au(I) phosphine drug Auranofin. J. Organomet. Chem.690(24–25), 5625–5635 (2005).
  • Özdemir I , DenizciA , ÖzturkHTet al. Synthetic and antimicrobial studies on new gold(I) complexes of imidazolidin-2-ylidenes. Appl. Organometal. Chem.18(7), 318–322 (2004).
  • Russel AD , PathFR , HugoWB. Antimicrobial activity and action of silver. Prog. Med. Chem.31, 351–370 (1994).
  • Lansdown ABG . A review of the use of silver in wound dressings: facts and fallacies. Br. J. Nurs.13, S6–S19 (2004).
  • Von Naegelli V . Silver nitrate: a very effective antimicrobial agent. Deut. Schr. Schweiz. Naturforsch. Ges.33, 174–182 (1893.
  • Dunn PM . Dr Carl Credé (1819–1892) and the prevention of ophthalmia neonatorum. Arch. Dis. Child. Fetal Neonatal Ed.83(2), F158–F159 (2000).
  • Lansdown ABG . Metallothioneins: potential therapeutic aids for wound healing in the skin. Wound Repair Reagen.10(3), 130–132 (2002).
  • Moyer CA . Treatment of large human burns with 0.5 per cent silver nitrate solution. Arch. Surg.90, 812–867 (1965).
  • National Institute of Standards and Technology . CRC Handbook of Chemistry and Physics (81st Edition). LideDR ( Ed.). CRC Press, FL, USA, 2556 (2000).
  • Hoffman RK , SurkiewiczBF , ChambersLAet al. Bactericidal action of movidyn. Ind. Eng. Chem.45(11), 2571–2573 (1953).
  • Davies O . They Didn't Listen, They Didn't Know How. Author House, IN, USA, 805 (2013).
  • Fox CL Jr . Silver sulfadiazine—a new topical therapy for Pseudomonas in burns. Therapy of Pseudomonas infection in burns. Arch. Surg.96(2), 184–188 (1968).
  • Fakhry SM , AlexanderJ , SmithDet al. Regional and institutional variation in burn care. J. Burn Care Rehabil.16(1), 86–90 (1995).
  • Kascatan-Nebioglu A , MelaiyeA , HindiKMet al. Synthesis from caffeine of a mixed N-heterocyclic carbine-silver acetate complex active against resistant respiratory pathogens. J. Med. Chem.49(23), 6811–6818 (2006).
  • Asekunowo PO , HaqueRA , RazaliMR. Sterically modulated silver(I) complexes of N-benzyl-substituted N-heterocyclic carbenes: synthesis, crystal structures and bioactivity. Transit. Met. Chem.40(1), 79–88 (2015).
  • Gök Y , AkkoçS , ÇelikalÖÖet al. In vitro antimicrobial studies of naphthalen-1-ylmethyl substituted silver N-heterocyclic carbene complexes. Arab. J. Chem.12(8), 2513–2518 (2019).
  • Gök Y , AkkoçS , ErdoğanH , AlbayrakS. In vitro antimicrobial studies of new benzimidazolium salts and silver N-heterocyclic carbene complexes. J. Enzyme Inhib. Med. Chem.31(6), 1322–1327 (2016).
  • Sakamoto R , MorozumiS , YanagawaYet al. Synthesis, characterization, and structure–activity relationship of the antimicrobial activities of dinuclear N-heterocyclic carbene (NHC)-silver(I) complexes. J. Inorg. Biochem.163, 110–117 (2016).
  • Aher S , DasA , MuskawarPet al. Synthesis, sharacterization and antimicrobial properties of methylbenzyl and nitrobenzyl containing imidazolium-based silver N-heterocyclic carbenes. J. Mol. Liq.233, 270–277 (2017).
  • Subramanya Prasad TV , ShahiniCR , PatilSAet al. Non-symmetrically p-nitrobenzyl- and p-cyanobenzyl-substituted N-heterocyclic carbene-silver(I) complexes: synthesis, characterization and antibacterial studies. J. Coord. Chem.70(4), 600–614 (2017).
  • O'Beirne C , AlhamadNF , MaQet al. Synthesis, structures and antimicrobial activity of novel NHC* and Ph3P-Ag(I)-benzoate derivatives. Inorganica Chim. Acta486, 294–303 (2019).
  • Shahini CR , AcharG , BudagumpiSet al. Synthesis, structural investigation and antibacterial studies of non-symmetrically p–nitrobenzyl substituted benzimidazole N-heterocyclic carbene-silver(I) complexes. Inorganica Chim. Acta466, 432–441 (2017).
  • Shahini CR , AcharG , BudagumpiSet al. Non-symmetrically p-nitrobenzyl-substituted N-heterocyclic carbine-silver(I) complexes as metallopharmaceutical agents. Appl. Organomet. Chem.31(12), e3819 (2017).
  • Kaloğlu N , Özdemirİ , GünalS , Özdemirİ. Synthesis and antimicrobial activity of bulky 3,5-di-tert-butyl substituent-containing silver–N-heterocyclic carbene complexes. Appl. Organomet. Chem.31(11), e3803 (2017).
  • Haque RA , HazizUFM , AbdullahAAAet al. New non-functionalized and nitrile-functionalized benzimidazolium salts and their silver(I) complexes: Synthesis, crystal structures and antibacterial studies. Polyhedron109, 208–217 (2016).
  • Haque RA , IqbalMA , MohamadF , RazaliMR. Antibacterial and DNA cleavage activity of carbonyl functionalized N-heterocyclic carbene-silver(I) and selenium compounds. J. Mol. Struct.1155, 362–370 (2018).
  • Asekunowo PO , HaqueRA , RazaliMohd Ret al. Synthesis and characterization of nitrile functionalized silver(I)-N-heterocyclic carbene complexes: DNA binding, cleavage studies, antibacterial properties and mosquitocidal activity against the dengue vector, aedes albopictus. Eur. J. Med. Chem.150, 601–615 (2018).
  • Karataş MO , OlgundenizB , GünalSet al. Synthesis, characterization and antimicrobial activities of novel silver(I) complexes with coumarin substituted N-heterocyclic carbene ligands. Bioorg. Med. Chem.24(4), 643–650 (2016).
  • Achar G , ShahiniCR , PatilSAet al. Coumarin-substituted 1,2,4-triazole-derived silver(I) and gold(I) complexes: Synthesis, characterization and anticancer studies. New J. Chem.43(3), 1216–1229 (2019).
  • Achar G , UppendranathK , RamyaVCet al. Synthesis, characterization, crystal structure and biological studies of silver(I) complexes derived from coumarin-tethered N-heterocyclic carbene ligands. Polyhedron123, 470–479 (2017).
  • Achar G , ShahiniCR , PatilSA , BudagumpiS. Synthesis, structural characterization, crystal structures and antibacterial potentials of coumarin-tethered N-heterocyclic carbene silver(I) complexes. J. Organomet. Chem.833, 28–42 (2017).
  • Streciwilk W , TerenziA , LoNardo Fet al. Synthesis and biological evaluation of organometallic complexes bearing bis-1,8-naphthalimide ligands. Eur. J. Inorg. Chem.2018(26), 3104–3112 (2018).
  • Achar G , ShahiniCR , PatilSAet al. Sterically modulated silver(I) complexes of coumarin substituted benzimidazol-2-ylidenes: synthesis, crystal structures and evaluation of their antimicrobial and antilung cancer potentials. J. Inorg. Biochem.183, 43–57 (2018).
  • Shahini CR , AcharG , BudagumpiSet al. Benzoxazole and dioxolane substituted benzimidazole-based N-heterocyclic carbine-silver(I) complexes: synthesis, structural characterization and in vitro antimicrobial activity. J. Organomet. Chem.868, 1–13 (2018).
  • Yıldırım I , AktaşA , CelepciDBet al. Synthesis, characterization, crystal structure, and antimicrobial studies of 2-morpholinoethyl-substituted benzimidazolium salts and their silver(I)-N-heterocyclic carbene complexes. Res. Chem. Intermed.43(11), 6379–6393 (2017).
  • Haziz UFM , HaqueRA , AmirulAAet al. Synthesis, structures and antibacterial studies of non-functionalized and nitrile-functionalized bis-benzimidazolium salts and respective dinuclear silver(I)-N-heterocyclic carbene complexes. Polyhedron117, 628–636 (2016).
  • Haziz UFM , HaqueRA , AmirulAAet al. New class of non-symmetrical homo-dibenzimidazolium salts and their dinuclear silver(I) di-NHC complexes. J. Organomet. Chem.899(30), 120914 (2019).
  • Loh YL , HazizUFM , HaqueRAet al. The effect of short alkane bridges in stability of bisbenzimidazole-2-ylidene silver(I) complexes: Synthesis, crystal structure and antibacterial activity. J. Coord. Chem.72(5–7), 894–907 (2019).
  • Haque RA , GhdhayebMZ , BudagumpiSet al. Synthesis, crystal structures, and in vitro anticancer properties of new N-heterocyclic carbene (NHC) silver(I)- and gold(I)/(III)-complexes: a rare example of silver(I)-NHC complex involved in redox transmetallation. RSC Adv.6(65), 60407–60421 (2016).
  • Ghdhayeb MZ , HaqueRA , BudagumpiSet al. Mono-and bis-N-heterocyclic carbene silver(I) and palladium(II) complexes: synthesis, characterization, crystal structure and in vitro anticancer studies. Polyhedron121, 222–230 (2017).
  • Atif M , BhattiHN , HaqueRAet al. Synthesis, structure, and anticancer activity of symmetrical and non-symmetrical silver(I)-N-heterocyclic carbene complexes. Appl. Biochem. Biotechnol.https://doi.org/10.1007/s12010-019-03186-9 (2020).
  • Hussaini SY , HaqueRA , FatimaTet al. Nitrile functionalized silver(I) N-heterocyclic carbene complexes: DFT calculations and antitumor studies. Transit. Met. Chem.43(4), 301–312 (2018).
  • Fatima T , HaqueRA , RazaliMRet al. Effect of lipophilicity of wingtip groups on the anticancer potential of mono N-heterocyclic carbene silver(I) complexes: synthesis, crystal structures and in vitro anticancer study. Appl. Organomet. Chem.31(10), e3735 (2017).
  • Asif M , IqbalMA , HusseinMAet al. Human colon cancer targeted pro-apoptotic, anti-metastatic and cytostatic effects of binuclear silver(I)-N-heterocyclic carbene (NHC) complexes. Eur. J. Med. Chem.108, 177–187 (2016).
  • Fatima T , HaqueRA , RazaliMRet al. Synthesis, crystal structure, in vitro anticancer and in vivo acute oral toxicity studies of tetramethylene linked bis-benzimidazolium salts and their respective dinuclear Ag(I)-NHC complexes. J. Coord. Chem.69(22), 3367–3383 (2016).
  • Haque RA , HasanudinN , HusseinMAet al. Bis-N-heterocyclic carbene silver(I) and palladium(II) complexes: efficient antiproliferative agents against breast cancer cells. Inorg. Nano-Met. Chem.47(1), 131–137 (2017).
  • Hussaini SY , HaquRA , AsekunowoPOet al. Synthesis, characterization and anti-proliferative activity of propylene linked bis-benzimidazolium salts and their respective dinuclear silver(I)-N-heterocyclic carbene complexes. J. Organomet. Chem.840, 56–62 (2017).
  • Salman AW , HaqueRA. Pd(II) and trinuclear Ag(I) Bis-N-heterocyclic carbene complexes: synthesis, structural and in vitro anticancer activity. Eur. J. Chem.7(1), 115–120 (2016).
  • Fatima T , HaqueRA , IqbalMAet al. Tetra N-heterocyclic carbene dinuclear silver(I) complexes as potential anticancer agents: synthesis and in vitro anticancer studies. J. Organomet. Chem.853, 122–135 (2017).
  • Higby GJ . Gold in medicine: a review of its use in the West before 1900. Gold Bull.15(4), 130–140 (1982).
  • Parish RV . Gold in medicine—chrysotherapy. Interdisc. Sci. Rev.17(3), 221–228 (1992).
  • Champion GD , GrahamGG , ZieglerJB. Chrysotherapy, treatment with gold-based drugs. Ballieres Clin. Rheumatol.4, 491–534 (1990).
  • Shaw CF III . Gold-based therapeutic agents. Chem. Rev.99(9), 2589–2600 (1999).
  • Jones WD . Diverse chemical applications of N-heterocyclic carbenes. J. Am. Chem. Soc.131(42), 15075–15077 (2009).
  • Mercsa L , AlbrechtM. Beyond catalysis: N-heterocyclic carbene complexes as components for medicinal, luminescent, and functional materials applications. Chem. Soc. Rev.39, 1903–1912 (2010).
  • Fung SK , ZouT , CaoBet al. Cyclometalated gold(III) complexes containing N-heterocyclic carbene ligands engage multiple anti-cancer molecular targets. Angew. Chem. Int. Ed.56(14), 3892–3896 (2017).
  • Streciwilk W , TerenziA , NardoFLet al. Synthesis and biological evaluation of organometallic complexes bearing bis-1,8-naphthalimide ligands. Eur. J. Inorg. Chem.2018(26), 3104–3112 (2018).
  • Vellé A , MaguireR , KavanaghKet al. Steroid-AuI-NHC complexes: synthesis and antibacterial activity. Chem. Med. Chem.12(11), 841–844 (2017).
  • Walthera W , DadaQ , CillianO'Beirne Cet al. In vitro and in vivo investigations into the carbene gold chloride and thioglucoside anticancer drug candidates NHC–AuCl and NHC–AuSR. Lett. Drug Des. Discov.14, 125–134 (2017).
  • Dada O , CurranD , O’BeirneCet al. Synthesis and cytotoxicity studies of novel NHC–Gold(I) pseudohalides and thiolates. J. Organomet. Chem.840, 30–37 (2017).
  • Dada O , Sánchez-SanzG , MatthiasTacke Met al. Synthesis and anticancer activity of novel NHC–gold(I)-sugar complexes. Tetrahedron Lett.59, 2904–2908 (2018).
  • Curran D , DadaO , Müller-BunzHet al. Synthesis and cytotoxicity studies of novel NHC*-gold(I) complexes derived from Lepidiline A. Molecules23(8), E2031 (2018).
  • Kapdi AR , FairlambIJS. Anti-cancer palladium complexes: a focus on PdX2L2, palladacycles and related complexes. Chem. Soc. Rev.43(13), 4751–4777 (2014).
  • Coskun MD , AriF , OralAYet al. Promising anti-growth effects of palladium(II) saccharinate complex of terpyridine by inducing apoptosis on transformed fibroblasts in vitro. Bioorg, Med. Chem.21(5), 4698–4705 (2013).
  • Choo KB , MahWL , LeeSUet al. Palladium complexes of bidentate pyridine N-heterocyclic carbenes: optical resolution, antimicrobial and cytotoxicity studies. Appl. Organometal. Chem.32(8), e4377 (2018).
  • Akkoç S , KayserV , İlhanİÖet al. New compounds based on a benzimidazole nucleus: synthesis, characterization and cytotoxic activity against breast and colon cancer cell lines. J. Organomet. Chem.839, 98–107 (2017).
  • Haque RA , HazizUFM , AmirulAAet al. Synthesis of a palladium(II) complex of a N-heterocylic carbene via transmetalation: crystal structure and antibacterial studies. Transit. Met. Chem.41, 775–781 (2016).
  • Hussaini SY , HaqueRA , FatimaTet al. Palladium(II) N-heterocyclic carbene complexes: synthesis, structures and cytotoxicity potential studies against breast cancer cell line. J. Coord. Chem.71(16–18), 2787–2799 (2018).
  • Hussaini SY , HaqueRA , TalebAghac Met al. Synthesis, structures and anticancer studies of symmetrically and nonsymmetrically aliphatic nitrile functionalized silver(I)-N-heterocyclic carbene and palladium(II)-N-heterocyclic carbene complexes. Inorg. Nano-met. Chem.48(4–5), 247–256 (2018).
  • Ghdhayeb MZ , HaqueRA , BudagumpiSet al. Synthesis, characterization, crystal structure and in vitro anticancer potentials of mono and bimetallic palladium(II)–N–heterocyclic carbene complexes. Inorg. Chem. Commun.75, 41–45 (2017).
  • Geldmacher Y , OleszakM , SheldrickWS. Rhodium(III) and iridium(III) complexes as anticancer agents. Inorg. Chim. Acta393, 84–102 (2012).
  • Oehninger L , SpreckelmeyerS , HolenyaPet al. Rhodium(I) N-heterocyclic carbene bioorganometallics as in vitro antiproliferative agents with Ddstinct effects on cellular signaling. J. Med. Chem.58(24), 9591–9600 (2015).
  • Zhang JJ , MuenznerJK , Abuel Maaty MAet al. A multi-target caffeine derived rhodium(I) N-heterocyclic carbene complex: evaluation of the mechanism of action. Dalton Trans.45, 13161–13168 (2016).
  • Fan R , BianM , HuLet al. A new rhodium(I) NHC complex inhibits TrxR: In vitro cytotoxicity and in vivo hepatocellular carcinoma suppression. Eur. J. Med. Chem.183, 111721 (2019).
  • Antonarakis ES , EmadiA. Ruthenium-based chemotherapeutics: are they ready for prime time?Cancer Chemoth. Pharm.66(1), 1–9 (2010).
  • Rademaker-Lakhai JM , vanden Bongard D , PluimDet al. A phase I and pharmacological study with imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a novel ruthenium anticancer agent. Clin. Cancer Res.10(11), 3717–3727 (2004).
  • Tabrizi L , OlasunkanmiLO , FadareOA. Experimental and theoretical investigations of cyclometalated ruthenium(II) complex containing CCC-pincer and anti-inflammatory drugs as ligands: synthesis, characterization, inhibition of cyclooxygenase and in vitro cytotoxicity activities in various cancer cell lines. Dalton Trans.48, 728–740 (2019).
  • Yang Y , GuoL , GeXet al. Novel lysosome-targeted cyclometalated iridium(III) anticancer complexes containing imine-N-heterocyclic carbene ligands: synthesis, spectroscopic properties and biological activity. Dyes Pigm.161, 119–129 (2019).
  • Li Y , LiuB , LuXet al. Cyclometalated iridium(III) N-heterocyclic carbene complexes as potential mitochondrial anticancer and photodynamic agents. Dalton Trans.46, 11363–11371 (2017).
  • Gothe Y , MarzoT , MessoriLet al. Iridium(I) compounds as prospective anticancer agents: solution chemistry, antiproliferative profiles and protein interactions for a series of iridium(I) N-heterocyclic carbene complexes. Chem. Eur. J.22(35), 12487–12494 (2016).
  • Daubit IM , Metzler-NolteN. On the interaction of N-heterocyclic carbene Ir+I complexes with His and Cys containing peptides. Dalton Trans.48, 13662–13673 (2019).
  • Sánchez-Mora A , ValdésH , Ramírez-ApanMTet al. NHC–Ir(I) complexes derived from 5,6-dinitrobenzimidazole. Synthesis, characterization and preliminary evaluation of their in vitro anticancer activity. Inorganica Chim. Acta496, 119061 (2019).
  • Eslava-Gonzalez I , ValdésH , Ramírez-ApanMTet al. Synthesis of theophylline-based iridium(I) N-heterocyclic carbene complexes including fluorinated-thiophenolate ligands. Preliminary evaluation of their in vitro anticancer activity. Inorganica Chim. Acta507, 119588 (2020).
  • Rosenberg B , van CampL , TroskoJE , MansourVH. Platinum compounds: a new class of potent antitumour agents. Nature222(5191), 385–386 (1969).
  • Kaim W , SchwederskiB. Bioanorganische Chemie (3rd Edition). Teubner, Stuttgart, Germany, 370 (2004).
  • Umapathy P . The chemical and biochemical consequences of the binding of the antitumour drug cisplatin and other platinum group metal complexes to DNA. Coordin. Chem. Rev.95(2), 129–181 (1989).
  • Harlepp S , ChardonE , BouchéMet al. N-Heterocyclic carbene-platinum complexes featuring an anthracenyl moiety: anti-cancer activity and DNA interaction. Int. J. Mol. Sci.20(17), E4198 (2019).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.